Clinical Trial Update: Methylphenidate Plus GWI-Nutrient Formula as a Treatment for Patients With Gulf War Illness [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 clinical trial evaluating methylphenidate plus a Gulf War Illness–specific nutrient formula for Gulf War Illness; the trial status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gulf War Illness

Drugs mentioned

• GWI-Nutrient Formula
• Methylphenidate (Methylphenidate)

Snippet

Sponsor: K-PAX Pharmaceuticals, Inc. | Conditions: Gulf War Illness | Phase 2 | Status: UNKNOWN